At new­ly rechris­tened Rakuten Med­ical, Japan­ese bil­lion­aire Mik­i­tani ups the ante with an­oth­er megaround

Mick­ey Mik­i­tani made it clear, over the three years he’s backed the San Diego start­up As­pyr­i­an Ther­a­peu­tics, that he’s ready to bet a for­tune of his mas­sive wealth — es­ti­mat­ed at $6.7 bil­lion — on its pho­toim­munother­a­py tech. The e-tail bil­lion­aire got in­volved ear­ly in the $40 mil­lion Se­ries A, pro­vid­ed the li­on’s share for the sub­se­quent rounds to­tal­ing $284 mil­lion, took charge first as chair­man then as CEO, and grad­u­al­ly in­te­grat­ed the biotech’s brand en­tire­ly in­to his Rakuten em­pire.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER